Population pharmacokinetics of intramuscular quinine in children with severe malaria
- PMID: 11353629
- PMCID: PMC90549
- DOI: 10.1128/AAC.45.6.1803-1809.2001
Population pharmacokinetics of intramuscular quinine in children with severe malaria
Abstract
We present the first population pharmacokinetic analysis of quinine in patients with Plasmodium falciparum malaria. Ghanaian children (n = 120; aged 12 months to 10 years) with severe malaria received an intramuscular loading dose of quinine dihydrochloride (20 mg/kg of body weight). A two-compartment model with first-order absorption and elimination gave post hoc estimates for pharmacokinetic parameters that were consistent with those derived from non-population pharmacokinetic studies (clearance [CL] = 0.05 liter/h/kg of body weight; volume of distribution in the central compartment [V(1)] = 0.65 liter/kg; volume of distribution at steady state = 1.41 liter/kg; half-life at beta phase = 19.9 h). There were no covariates (including age, gender, acidemia, anemia, coma, parasitemia, or anticonvulsant use) that explained interpatient variability in weight-normalized CL and V(1). Intramuscular quinine was associated with minor, local toxicity in some patients (13 of 108; 12%), and 11 patients (10%) experienced one or more episodes of postadmission hypoglycemia. A loading dose of intramuscular quinine results in predictable population pharmacokinetic profiles in children with severe malaria and may be preferred to the intravenous route of administration in some circumstances.
Figures




Similar articles
-
Population pharmacokinetic and pharmacodynamic properties of intramuscular quinine in Tanzanian children with severe Falciparum malaria.Antimicrob Agents Chemother. 2013 Feb;57(2):775-83. doi: 10.1128/AAC.01349-12. Epub 2012 Nov 26. Antimicrob Agents Chemother. 2013. PMID: 23183442 Free PMC article. Clinical Trial.
-
Dose-dependent resorption of quinine after intrarectal administration to children with moderate Plasmodium falciparum malaria.Antimicrob Agents Chemother. 2004 Nov;48(11):4422-6. doi: 10.1128/AAC.48.11.4422-4426.2004. Antimicrob Agents Chemother. 2004. PMID: 15504872 Free PMC article. Clinical Trial.
-
Quinine pharmacokinetics and pharmacodynamics in children with malaria caused by Plasmodium falciparum.Antimicrob Agents Chemother. 2005 Sep;49(9):3658-62. doi: 10.1128/AAC.49.9.3658-3662.2005. Antimicrob Agents Chemother. 2005. PMID: 16127036 Free PMC article. Clinical Trial.
-
Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.Clin Pharmacokinet. 1996 Apr;30(4):263-99. doi: 10.2165/00003088-199630040-00002. Clin Pharmacokinet. 1996. PMID: 8983859 Review.
-
Artemether for severe malaria.Cochrane Database Syst Rev. 2019 Jun 18;6(6):CD010678. doi: 10.1002/14651858.CD010678.pub3. Cochrane Database Syst Rev. 2019. PMID: 31210357 Free PMC article.
Cited by
-
Treatment of African children with severe malaria - towards evidence-informed clinical practice using GRADE.Malar J. 2011 Jul 21;10:201. doi: 10.1186/1475-2875-10-201. Malar J. 2011. PMID: 21777441 Free PMC article. Review.
-
Intramuscular Artesunate for Severe Malaria in African Children: A Multicenter Randomized Controlled Trial.PLoS Med. 2016 Jan 12;13(1):e1001938. doi: 10.1371/journal.pmed.1001938. eCollection 2016 Jan. PLoS Med. 2016. PMID: 26757276 Free PMC article. Clinical Trial.
-
Pharmacokinetic interactions between ritonavir and quinine in healthy volunteers following concurrent administration.Br J Clin Pharmacol. 2010 Mar;69(3):262-70. doi: 10.1111/j.1365-2125.2009.03566.x. Br J Clin Pharmacol. 2010. PMID: 20233197 Free PMC article. Clinical Trial.
-
Intramuscular bioavailability and clinical efficacy of artesunate in gabonese children with severe malaria.Antimicrob Agents Chemother. 2002 Dec;46(12):3933-9. doi: 10.1128/AAC.46.12.3933-3939.2002. Antimicrob Agents Chemother. 2002. PMID: 12435698 Free PMC article. Clinical Trial.
-
Defining the next generation of severe malaria treatment: a target product profile.Malar J. 2024 Jun 5;23(1):174. doi: 10.1186/s12936-024-04986-z. Malar J. 2024. PMID: 38835069 Free PMC article. Review.
References
-
- Agbenyega T, Angus B, Bedu-Addo G, Baffoe-Bonnie B, Guyton T, Stacpoole P, Krishna S. Glucose and lactate kinetics in children with severe malaria. J Clin Endocrinol Metab. 2000;85:1569–1576. - PubMed
-
- Barennes H. Intramuscular injections in sub-Saharan African children, apropos of a frequently misunderstood pathology: the complications related to intramuscular quinine injections. Bull Soc Pathol Exot. 1999;92:33–37. . (In French.) - PubMed
-
- Brodribb C. Quinine necrosis of muscle. Br Med J. 1922;ii:109.
-
- English M, Wale S, Binns G, Mwangi I, Sauerwein H, Marsh K. Hypoglycaemia on and after admission in Kenyan children with severe malaria. QJM. 1998;91:191–197. - PubMed
-
- Fletcher W. Notes on the treatment of malaria with the alkaloids of cinchona. Vol. 18. London, United Kingdom: John Bale, Sons & Danielsson, Ltd.; 1928.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources